Regulus Therapeutics Inc.

RGLS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
RGLS Income Statement
RGLS Balance Sheet
RGLS Cash Flow
Congress Trading

Recent trades of RGLS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
RGLS Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
RGLS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
RGLS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by RGLS's directors and management

Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
Corporate Lobbying

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Galnac conjugated modified oligonucleotides as mir-122 inhibitor having hcv antiviral activity with reduced hyperbilirubinemia side-effect Jun. 11, 2024
  • Patent Title: Methods for treatment of polycystic kidney disease Nov. 09, 2021
  • Patent Title: Compounds and methods for enhanced cellular uptake Mar. 09, 2021
  • Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Mar. 10, 2020
  • Patent Title: Targeting micrornas for the treatment of liver cancer May. 28, 2019
  • Patent Title: Compounds and methods for enhanced cellular uptake Mar. 26, 2019
  • Patent Title: Microrna compounds and methods for modulating mir-122 Dec. 11, 2018
  • Patent Title: Targeting micrornas for metabolic disorders Nov. 27, 2018
  • Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Oct. 09, 2018
  • Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Sep. 11, 2018
  • Patent Title: Microrna compounds and methods for modulating mir-21 activity Jun. 12, 2018
  • Patent Title: Methods for use in modulating mir-122a Jun. 12, 2018
  • Patent Title: Methods for treatment of alport syndrome May. 15, 2018
  • Patent Title: Microrna compounds and methods for modulating mir-21 activity May. 15, 2018
  • Patent Title: Targeting micrornas for the treatment of fibrosis May. 15, 2018
  • Patent Title: Targeting micrornas for metabolic disorders Jan. 09, 2018
  • Patent Title: Targeting micrornas for the treatment of liver cancer Dec. 19, 2017
  • Patent Title: Microrna compounds and methods for modulating mir-21 activity Oct. 17, 2017
  • Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Sep. 05, 2017
  • Patent Title: Methods for treatment of alport syndrome Jun. 27, 2017
  • Patent Title: Microrna compounds and methods for modulating mir-21 activity Jun. 27, 2017
  • Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas May. 30, 2017
  • Patent Title: Microrna compounds and methods for modulating mir-122 Feb. 21, 2017
  • Patent Title: Targeting micrornas for the treatment of fibrosis Jan. 31, 2017
  • Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Dec. 27, 2016
  • Patent Title: Targeting micrornas for the treatment of liver cancer Nov. 29, 2016
  • Patent Title: Compounds and methods for enhanced cellular uptake Nov. 29, 2016
  • Patent Title: Targeting micrornas for metabolic disorders Nov. 08, 2016
  • Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Sep. 20, 2016
  • Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Sep. 20, 2016
  • Patent Title: Methods for treatment of alport syndrome Jun. 07, 2016
  • Patent Title: Microrna compounds and methods for modulating mir-122 Apr. 12, 2016
  • Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Feb. 23, 2016
  • Patent Title: Microrna compounds and methods for modulating mir-21 activity Feb. 23, 2016
  • Patent Title: Targeting micrornas for the treatment of fibrosis Nov. 10, 2015
  • Patent Title: Microrna compounds and methods for modulating mir-21 activity Nov. 10, 2015
  • Patent Title: Microrna compounds and methods for modulating mir-122 Oct. 13, 2015
  • Patent Title: Targeting micrornas for the treatment of liver cancer Oct. 06, 2015
  • Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Sep. 22, 2015
  • Patent Title: Methods for treatment of alport syndrome Apr. 21, 2015
  • Patent Title: Microrna compounds and methods for modulating mir-21 activity Mar. 03, 2015
  • Patent Title: Methods for use in modulating mir-122a Mar. 03, 2015
  • Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Feb. 03, 2015
  • Patent Title: Microrna compounds and methods for modulating mir-21 activity Dec. 16, 2014
  • Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Oct. 14, 2014
  • Patent Title: Microrna compositions and methods Sep. 30, 2014
  • Patent Title: Targeting micrornas for the treatment of fibrosis Aug. 26, 2014
  • Patent Title: Method of inhibiting mir-33 using a modified oligonucleotide Aug. 19, 2014
  • Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Jul. 01, 2014
  • Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Apr. 15, 2014
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of RGLS in WallStreetBets Daily Discussion

RGLS News

Recent insights relating to RGLS

CNBC Recommendations

Recent picks made for RGLS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RGLS

RGLS Top Shareholders
Shareholder
Shares Held
RGLS Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

RGLS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view RGLS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top